| Patent application number | Description | Published |
|---|
| 20090041698 | Cosmetic product in the form of compact powder comprising a message informing the user - A compressed powder product ( | 02-12-2009 |
| 20090081783 | Method for producing langerhans cells or interstitial dendritic cells or both from CD14+ monocytes - The present invention relates to a method for preparing Langerhans cells or interstitial dendritic cells, or both, from CD14 | 03-26-2009 |
| 20090098171 | Cosmetic composition in the form of an emulsion comprising a continuous aqueous phase and a dispersed fatty phase, and method for its preparation - The invention relates to a composition in the form of an emulsion comprising a continuous aqueous phase and a dispersed fatty phase, characterized in that said aqueous phase contains liposomes in the presence of a non-ionic surfactant chosen from fatty alcohol polyethylene glycol ethers and fatty alcohol polypropylene glycol ethers, and mixtures thereof, and of at least one polysaccharide in water-soluble form. | 04-16-2009 |
| 20090104258 | Use of tocopheryl phosphate as an agent for preventing or slowing down the appearance of the effects of skin ageing - The invention relates to a cosmetic composition of a tocopheryl phosphate, especially in its dl or d form, or in the form of a cosmetically acceptable salt or ester thereof, as a cosmetic agent for preventing or slowing down the appearance of the effects of skin ageing, in particular of photoageing of the skin, said tocopheryl phosphate being at least partially encapsulated in lipid vesicles, in particular liposomes. It relates most particularly to the use of alpha-tocopheryl phosphate. It also relates to cosmetic compositions containing a tocopheryl phosphate, in particular an alpha-tocopheryl phosphate, at least partially incorporated into lipid vesicles, in particular liposomes, these compositions being in particular in the form of a serum or of a stable emulsion. The invention also relates to a cosmetic skincare process. | 04-23-2009 |
| 20100040710 | Stimulation of the synthesis and of the activity of an isoform of lysyl oxidase-like LOXL for stimulating the formation of elastic fibers. - The invention relates to the stimulation of the synthesis and of the activity of an isoform of lysyl oxidase, and more particularly of the LOXL (lysyl oxidase-like) isoform. | 02-18-2010 |
| 20100047361 | Active Principle which is capable of inducing the conversion of inactive TGFb-Latent into active TGFb - The invention relates to active principles which are capable of inducing the conversion of inactive TGFb-Latent into active TGFb. The invention relates in particular to the use of such an extract for the manufacture of a composition for increasing the concentration of active TGFb1 in the skin, notably in the dermis. | 02-25-2010 |
| 20100080787 | COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION COMPRISING AN ENZYME WHICH IS INSOLUBLE IN AN AQUEOUS MEDIUM AS WELL AS ITS USES - The invention relates to a cosmetic or dermopharmaceutical composition, as well as these uses. | 04-01-2010 |
| 20100203175 | DEGLYCATION OF AGEs - The invention relates to the use, as an active ingredient, of at least one substance that promotes the deglycation of AGEs for preparing a composition, especially for limiting the presence of AGEs in a tissue. | 08-12-2010 |
| 20100209407 | MC-1R, MC-2R, AND/OR MU OPIOID RECEPTORS MODULATION - The invention concerns active substances modulating the expression of the receptors of the products of the POMC gene (MC-IR, MC-2R, and the μ opioid receptor), and possibly modulating the expression of POMC in cutaneous cells, notably to modulate the proliferation and differentiation of epidermal cells in order to re-epithelial, maintain innervation, irrigate the skin, or restore normal pigmentation, or to fight against aging, or to modulate pigmentation independently or not of cutaneous aging. The invention also concerns a method of screening such active substances. | 08-19-2010 |
| 20100272699 | MC-1R, MC-2R, and/or OPIOID RECEPTORS STIMULATION - The invention concerns active substances modulating the expression of the receptors of the products of the POMC gene (MC-IR, MC-2R, and the μ opioid receptor), and possibly modulating the expression of POMC in cutaneous cells, notably to modulate the proliferation and differentiation of epidermal cells in order to re-epithelial, maintain innervation, irrigate the skin, or to fight against aging, or to modulate pigmentation independently or not of cutaneous aging. The invention also concerns a method of screening such active substances. | 10-28-2010 |
| 20100297765 | METHOD FOR PRODUCING LANGERHANS CELLS OR INTERSTITIAL DENDRITIC CELLS OR BOTH FROM CD14+ MONOCYTES - The present invention relates to a method for preparing Langerhans cells or interstitial dendritic cells or both from CD14 | 11-25-2010 |
| 20100316743 | INHIBITION OF THE FORMATION OF AGEs - The present invention relates to the use of an active substance that promotes the inhibition of the formation of AGEs, for preparing a composition to prevent and/or combat the reduction in elastic and plastic properties of tissues, and in particular of the skin, for inhibiting the formation of AGEs, or for preventing and/or combating glycation of proteins in the skin. | 12-16-2010 |
| 20110014175 | STIMULATION OF THE SYNTHESIS OF THE ACTIVITY OF AN ISOFORM OF LYSL OXIDASE-LIKE LOXL FOR STIMULATING THE FORMATION OF ELASTIC FIBRES - The invention relates to the stimulation of the synthesis and of the activity of an isoform of lysyl oxidase, and more particularly of the LOXL (lysyl oxidase-like) isoform. | 01-20-2011 |
